News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Zev A. Wainberg, MD, UCLA Medical Center

Articles by Zev A. Wainberg, MD, UCLA Medical Center

Pancreatic Cancer Updates

ByYelena Y. Janjigian, MD, Memorial Sloan Kettering Cancer Center,Jaffer A. Ajani, MD, MD Anderson Cancer Center,Daniel Catenacci, MD, University of Chicago Medicine,Zev A. Wainberg, MD, UCLA Medical Center

August 10th 2020

Liver Cancer Updates

ByYelena Y. Janjigian, MD, Memorial Sloan Kettering Cancer Center,Jaffer A. Ajani, MD, MD Anderson Cancer Center,Daniel Catenacci, MD, University of Chicago Medicine,Zev A. Wainberg, MD, UCLA Medical Center

August 10th 2020

Gastric Cancer Updates

ByYelena Y. Janjigian, MD, Memorial Sloan Kettering Cancer Center,Jaffer A. Ajani, MD, MD Anderson Cancer Center,Daniel Catenacci, MD, University of Chicago Medicine,Zev A. Wainberg, MD, UCLA Medical Center

August 10th 2020

Colorectal Cancer Updates

ByYelena Y. Janjigian, MD, Memorial Sloan Kettering Cancer Center,Jaffer A. Ajani, MD, MD Anderson Cancer Center,Daniel Catenacci, MD, University of Chicago Medicine,Zev A. Wainberg, MD, UCLA Medical Center

August 10th 2020

Latest Updated Articles

Colorectal Cancer Updates
August 10th 2020
Liver Cancer Updates
August 10th 2020
Pancreatic Cancer Updates
August 10th 2020
Gastric Cancer Updates
August 10th 2020

Trending on OncLive

Epcoritamab Plus Lenalidomide/Rituximab Win EU Approval for R/R Follicular Lymphoma

FDA Issues CRL to Orviglance for Liver Metastasis Imaging in Patients With Severe Kidney Impairment

Adagrasib Plus Cetuximab Misses OS, PFS End Points in Pretreated KRAS G12C–Mutated CRC

Phase 1 Data Highlight Potential Utility for In Vivo CAR T-Cell Therapy in R/R Myeloma

Dr Spencer on Differentiating Factors for In Vivo CAR T-Cell Therapy in Myeloma